InnoSer is at AACR with its Oncology Offerings

InnoSer is at AACR with its Oncology Offerings

Innoser is putting oncology development at the forefront of our efforts this year. By attending this year’s AACR 2021, we hope to improve our innovative oncology offerings and learn from the best. This year the American Association for Cancer Research is hosting...
BlastomaBrain: New in vitro platform for oncology drug development

BlastomaBrain: New in vitro platform for oncology drug development

One of the greatest challenges in drug development is ensuring that the safety and efficacy results from early stages (i.e. from tests on cultured cells or animal models) translate well to administrating the drugs to humans. The gap between the results from these...
InnoSer offers new in vivo imaging capabilities

InnoSer offers new in vivo imaging capabilities

InnoSer is acquiring a variety of preclinical imaging modalities for its Diepenbeek facility to offer its customers a comprehensive assessment of their models and compounds. Non-invasive and high-throughput kinetic assays with real-time readouts will improve screening...
InnoSer welcomes Edith Simar as its new Business Development Manager

InnoSer welcomes Edith Simar as its new Business Development Manager

Starting from September 2020, Edith Simar joined the InnoSer team as a business development manager. Thanks to her earlier work and connections in Belgium, France, and Luxembourg Edith will especially strengthen InnoSer’s relationships with (prospective) French...